Cargando…

A Canadian Perspective on the Challenges for Delivery of Curative-Intent Therapy in Stage III Unresectable Non-Small Cell Lung Cancer

Stage III non-small cell lung cancer (NSCLC) comprises a highly heterogenous group of patients with regards to patient fitness and tumour size and distribution, resulting in a wide range of treatment goals and therapy options. Curative-intent multimodality treatment should be considered in all patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brade, Anthony, Jao, Kevin, Yu, Simon, Cheema, Parneet, Doucette, Sarah, Christofides, Anna, Schellenberg, Devin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161772/ https://www.ncbi.nlm.nih.gov/pubmed/33923355 http://dx.doi.org/10.3390/curroncol28030151

Ejemplares similares

Emerging Systemic Therapies in Advanced Unresectable Biliary Tract Cancer: Review and Canadian Perspective †
por: Tam, Vincent C., et al.
Publicado: (2022)

Follow-Up Imaging Guidelines for Patients with Stage III Unresectable NSCLC: Recommendations Based on the PACIFIC Trial
por: Ko, Jenny J., et al.
Publicado: (2023)

The Evolving Role of Immunotherapy in Stage III Non-Small Cell Lung Cancer
por: Perdrizet, Kirstin, et al.
Publicado: (2021)

Canadian Consensus Recommendations on the Management of Extensive-Stage Small-Cell Lung Cancer
por: Melosky, Barbara L., et al.
Publicado: (2023)

A Canadian Perspective on the Treatment of Waldenström Macroglobulinemia
por: Kaedbey, Rayan, et al.
Publicado: (2022)

Changing and challenging times for Canadian kidney health and disease research
por: Kennedy, C. R. J.
Publicado: (2015)

Resource-sparing curative-intent hypofractionated-accelerated radiotherapy in head and neck cancer: More relevant than ever before in the COVID era
por: Gupta, Tejpal, et al.
Publicado: (2020)

The cost of unresectable stage III or stage IV melanoma in Italy
por: Maio, Michele, et al.
Publicado: (2012)

Curative-Intent Treatment with Durvalumab in Early-Stage Cancers
por: Melillo, Giovanni, et al.
Publicado: (2021)

A Pan-Canadian Consensus Statement on First-Line PARP Inhibitor Maintenance for Advanced, High-Grade Serous and Endometrioid Tubal, Ovarian, and Primary Peritoneal Cancers
por: Tinker, Anna V., et al.
Publicado: (2022)

Burden of spousal caregivers of stage II and III esophageal cancer survivors 3 years after treatment with curative intent
por: Haj Mohammad, N., et al.
Publicado: (2015)

Current challenges of unresectable stage III NSCLC: are we ready to break the glass ceiling of the PACIFIC trial?
por: Remon, Jordi, et al.
Publicado: (2022)

Potential tactics with certain gut microbiota for the treatment of unresectable hepatocellular carcinoma
por: Yoshikawa, Sayuri, et al.
Publicado: (2023)

Can we replace curation with information extraction software?
por: Karp, Peter D.
Publicado: (2016)

Crowd-sourcing and author submission as alternatives to professional curation
por: Karp, Peter D.
Publicado: (2016)

Open source automated insulin delivery: addressing the challenge
por: Oliver, Nick, et al.
Publicado: (2019)

Principles of Intentional Mentoring
por: Werner-Washburne, Margaret
Publicado: (2018)

The Rat Genome Database Curators: Who, What, Where, Why
por: Shimoyama, Mary, et al.
Publicado: (2009)

Surgery with curative intent for stage IV gastric cancer: Is it a reality of illusion?
por: Kodera, Yasuhiro
Publicado: (2018)

Imaging of early-stage osteoarthritis: the needs and challenges for diagnosis and classification
por: Oei, Edwin H. G., et al.
Publicado: (2023)

Therapeutic revolution for inoperable stage III non-small cell lung cancer in the immune era
por: Li, Jiakang, et al.
Publicado: (2022)

Vulnerability of Canadian aquatic ecosystems to nuclear accidents
por: Brinkmann, Lars, et al.
Publicado: (2017)

What Does CLARITY-BPA Mean for Canadians?
por: Rogers, Lindsay D.
Publicado: (2021)

Targeted therapies for unresectable stage III non-small cell lung cancer
por: Remon, Jordi, et al.
Publicado: (2021)

Curative and health enhancement effects of aquatic exercise: evidence based on interventional studies
por: Honda, Takuya, et al.
Publicado: (2012)

Nanoparticle-Mediated Cytoplasmic Delivery of Messenger RNA Vaccines: Challenges and Future Perspectives
por: Wu, Zimei, et al.
Publicado: (2021)

Involving community in genes and pathway curation
por: Naithani, Sushma, et al.
Publicado: (2019)

Analysis of Why Alzheimer’s Dementia Never Spontaneously Reverses, Suggests the Basis for Curative Treatment
por: Fessel, Jeffrey
Publicado: (2023)

Improving health-care delivery in low-resource settings with nanotechnology: Challenges in multiple dimensions
por: Abbas, James J, et al.
Publicado: (2017)

Formalizing drug indications on the road to therapeutic intent
por: Nelson, Stuart J, et al.
Publicado: (2017)

Real-World Journey of Unresectable Stage III NSCLC Patients: Current Dilemmas for Disease Staging and Treatment
por: Agbarya, Abed, et al.
Publicado: (2022)

Noni MacDonald: inspirational leader in Canadian and global health
por: Lane, Richard
Publicado: (2020)

Integrating Patient-Centred Research in the Canadian Cancer Trials Group
por: Needham, J., et al.
Publicado: (2021)

A systematic review of randomized controlled trials on curative and health enhancement effects of forest therapy
por: Kamioka, Hiroharu, et al.
Publicado: (2012)

Integrative biological simulation praxis: Considerations from physics, philosophy, and data/model curation practices
por: Sarma, Gopal P., et al.
Publicado: (2017)

The benefit of the doubt: PD-L1 status in unresectable stage III NSCLC management
por: Denault, Marie-Helene, et al.
Publicado: (2023)

Optimizing Interprofessional Simulation with Intentional Pre-Briefing and Debriefing
por: Penn, Jennifer, et al.
Publicado: (2023)

Governing Collaborative Healthcare Improvement: Lessons From an Atlantic Canadian Case
por: Rossiter, Meghan, et al.
Publicado: (2017)

Recommendations of the 5th Canadian Consensus Conference on the diagnosis and treatment of dementia
por: Ismail, Zahinoor, et al.
Publicado: (2020)

The Canadian Open Neuroscience Platform—An open science framework for the neuroscience community
por: Harding, Rachel J., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qi0ek0kvts4qttfv7fjb04spgb